Jiangxi Fushine Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 775.845 million compared to CNY 816.401 million a year ago. Operating income was CNY 176.997 million compared to CNY 272.544 million a year ago. Net income was CNY 152.370 million compared to CNY 219.258 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.49 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.47 a year ago.